| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts from the ASENT 2006 Annual Meeting March 8–11, 2006
|
Pritchett, Y.
|
|
2006
|
3 |
3 |
p. 407-415
|
artikel
|
| 2 |
An Analysis of Correlations Among 4 Outcome Scales Employed in Clinical Trials of Patients With Major Depressive Disorder
|
Jiang, Q.
|
|
2006
|
3 |
3 |
p. 411-412
2 p.
|
artikel
|
| 3 |
Androstenol (5α-androst-16-en-3α-ol) Is a Novel Neurosteroid Positive Modulator of GABAA Receptors: In Vitro and In Vivo Studies
|
Kaminski, R.M.
|
|
2006
|
3 |
3 |
p. 413-414
2 p.
|
artikel
|
| 4 |
Antiepileptic Drugs Do Not Affect 5-HT1A Receptor Binding Measured by Positron Emission Topography
|
Theodore, W.
|
|
2006
|
3 |
3 |
p. 410-
1 p.
|
artikel
|
| 5 |
Assessing the Signal Detection Properties of 3 Outcome Scales Used in Clinical Trials of Patients with Generalized Anxiety Disorder
|
Jiang, Q.
|
|
2006
|
3 |
3 |
p. 411-
1 p.
|
artikel
|
| 6 |
Cardiovascular Effects of Duloxetine: Preclinical and Clinical Findings
|
Detke, M.
|
|
2006
|
3 |
3 |
p. 407-408
2 p.
|
artikel
|
| 7 |
Characterization of Soluble Fas Receptor as a Neuroprotective Agent following Acute Spinal Cord Injury
|
Robins, S.
|
|
2006
|
3 |
3 |
p. 412-
1 p.
|
artikel
|
| 8 |
CT Scan Hematoma Volume: A Surrogate Endpoint for the Effect of Treatment in Intracerebral Hemorrhage
|
Skolnick, B.E.
|
|
2006
|
3 |
3 |
p. 413-
1 p.
|
artikel
|
| 9 |
Development of 1-Octanol as a Novel Therapy for the Treatment of Ethanol-Responsive Essential Tremor
|
Nahab, F.
|
|
2006
|
3 |
3 |
p. 410-411
2 p.
|
artikel
|
| 10 |
Dose Decrease and Other Correlates of Relapse in Patients with Schizophrenia or Schizoaffective Disorder During Olanzapine Drug Therapy
|
Deberdt, W.
|
|
2006
|
3 |
3 |
p. 409-
1 p.
|
artikel
|
| 11 |
Duloxetine in the Management of Diabetic Peripheral Neuropathic Pain: Response Profile
|
Pritchett, Y.
|
|
2006
|
3 |
3 |
p. 407-
1 p.
|
artikel
|
| 12 |
Dystonia Medical Research Foundation: 30 Years of Promoting Research and Therapy Development
|
|
|
2006
|
3 |
3 |
p. 414-415
2 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2006
|
3 |
3 |
p. i-
1 p.
|
artikel
|
| 14 |
Evaluation of Duloxetine Effectiveness in the Management of DPNP with Respect to Baseline Characteristics
|
Pritchett, Y.
|
|
2006
|
3 |
3 |
p. 407-
1 p.
|
artikel
|
| 15 |
Evaluation of Polyethylene Glycol as a Neuroprotective Strategy for Acute Spinal Cord Injury
|
Baptiste, D.
|
|
2006
|
3 |
3 |
p. 413-
1 p.
|
artikel
|
| 16 |
Identification of a Rapid-Throughput Battery of Pheontypic Tests for Drug Candidate Evaluation in the Δ-7 Mouse Model of Spinal Muscular Atrophy
|
El-Khodor, B.
|
|
2006
|
3 |
3 |
p. 411-
1 p.
|
artikel
|
| 17 |
Imaging of Neurotransmitter Deficits: New Potential Biomarkers for Alzheimer’s Disease?
|
Herholz, K.
|
|
2006
|
3 |
3 |
p. 412-
1 p.
|
artikel
|
| 18 |
Liquid Chromatography with Tandem Mass Spectrometry-Based Proteomic Discovery in Aging and Alzheimer’s Disease
|
Montine, Thomas J.
|
|
2006
|
3 |
3 |
p. 336-343
8 p.
|
artikel
|
| 19 |
Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer’s disease
|
Montine, Thomas J.
|
|
2006
|
3 |
3 |
p. 336-343
|
artikel
|
| 20 |
Measuring Cortical Acetylcholine Esterase Activity by PET in Dementia: Clinical Correlates
|
Herholz, K.
|
|
2006
|
3 |
3 |
p. 410-
1 p.
|
artikel
|
| 21 |
Microarrays in Parkinson’s disease: A systematic approach
|
Miller, Renee M.
|
|
2006
|
3 |
3 |
p. 319-326
|
artikel
|
| 22 |
Microarrays in Parkinson’s Disease: A Systematic Approach
|
Miller, Renee M.
|
|
2006
|
3 |
3 |
p. 319-326
8 p.
|
artikel
|
| 23 |
Molecular Genetics of Addiction Vulnerability
|
Uhl, George R.
|
|
2006
|
3 |
3 |
p. 295-301
7 p.
|
artikel
|
| 24 |
Molecular genetics of addiction vulnerability
|
Uhl, George R.
|
|
2006
|
3 |
3 |
p. 295-301
|
artikel
|
| 25 |
Neurosurgical Treatment of Intractable Tourette’s Syndrome: A Scientific Clinical Review of Literatures
|
Meratee, M.
|
|
2006
|
3 |
3 |
p. 408-
1 p.
|
artikel
|
| 26 |
NIH Countermeasures Against Chemical Threats (CounterACT) Research Program
|
Jett, D.
|
|
2006
|
3 |
3 |
p. 409-
1 p.
|
artikel
|
| 27 |
Noninvasive Measurement and Quantitation of Brain Iron in Parkinson’s Disease Using Adiabatic T2ρ and T1ρ High Field MRI Techniques
|
Michaeli, S.
|
|
2006
|
3 |
3 |
p. 408-409
2 p.
|
artikel
|
| 28 |
Prediction of Combined Symptomatic and Functional Outcome in Patients with Schizophrenia or Schizoaffective Disorder
|
Lipkovich, I.
|
|
2006
|
3 |
3 |
p. 410-
1 p.
|
artikel
|
| 29 |
Prolonged Attenuation of Amygdla Kindled Seizures by Local Delivery of Large Molecular Weight Therapeutic Agents by Convection-Enhanced Delivery in Rats
|
Gasior, M.
|
|
2006
|
3 |
3 |
p. 414-
1 p.
|
artikel
|
| 30 |
Redox proteomics in some age-related neurodegenerative disorders or models thereof
|
Butterfield, D. Allan
|
|
2006
|
3 |
3 |
p. 344-357
|
artikel
|
| 31 |
Redox Proteomics in Some Age-Related Neurodegenerative Disorders or Models Thereof
|
Butterfield, D. Allan
|
|
2006
|
3 |
3 |
p. 344-357
14 p.
|
artikel
|
| 32 |
Single Cell Gene Expression Profiling in Alzheimer’s Disease
|
Ginsberg, Stephen D.
|
|
2006
|
3 |
3 |
p. 302-318
17 p.
|
artikel
|
| 33 |
Single cell gene expression profiling in Alzheimer’s disease
|
Ginsberg, Stephen D.
|
|
2006
|
3 |
3 |
p. 302-318
|
artikel
|
| 34 |
Survey on Patient and Physician Attitudes about Parkinson Clinical Trials
|
|
|
2006
|
3 |
3 |
p. 415-
1 p.
|
artikel
|
| 35 |
Systems Biology: A Primer
|
Federoff, Howard J.
|
|
2006
|
3 |
3 |
p. 293-294
2 p.
|
artikel
|
| 36 |
Systems biology: A primer
|
Federoff, Howard J.
|
|
2006
|
3 |
3 |
p. 293-294
|
artikel
|
| 37 |
The application of NMR-based metabonomics in neurological disorders
|
Holmes, Elaine
|
|
2006
|
3 |
3 |
p. 358-372
|
artikel
|
| 38 |
The Application of NMR-Based Metabonomics in Neurological Disorders
|
Holmes, Elaine
|
|
2006
|
3 |
3 |
p. 358-372
15 p.
|
artikel
|
| 39 |
The Cognitive Phenotype of Down Syndrome: Insights from Intracellular Network Analysis
|
Ma’ayan, Avi
|
|
2006
|
3 |
3 |
p. 396-406
11 p.
|
artikel
|
| 40 |
The cognitive phenotype of Down syndrome: Insights from intracellular network analysis
|
Ma’ayan, Avi
|
|
2006
|
3 |
3 |
p. 396-406
|
artikel
|
| 41 |
The Microarray Data Analysis Process: From Raw Data to Biological Significance
|
Olson, N. Eric
|
|
2006
|
3 |
3 |
p. 373-383
11 p.
|
artikel
|
| 42 |
The microarray data analysis process: From raw data to biological significance
|
Olson, N. Eric
|
|
2006
|
3 |
3 |
p. 373-383
|
artikel
|
| 43 |
The Role of Microglia and NADPH Oxidase in Traumatic Spinal Cord Injury
|
Byrnes, K.
|
|
2006
|
3 |
3 |
p. 408-
1 p.
|
artikel
|
| 44 |
Two-dimensional Protein Electrophoresis: From Molecular Pathway Discovery to Biomarker Discovery in Neurological Disorders
|
Choe, Leila H.
|
|
2006
|
3 |
3 |
p. 327-335
9 p.
|
artikel
|
| 45 |
Two-dimensional protein electrophoresis: From molecular pathway discovery to biomarker discovery in neurological disorders
|
Choe, Leila H.
|
|
2006
|
3 |
3 |
p. 327-335
|
artikel
|
| 46 |
Utility of Correlation Measures in Analysis of Gene Expression
|
Almudevar, Anthony
|
|
2006
|
3 |
3 |
p. 384-395
12 p.
|
artikel
|
| 47 |
Utility of correlation measures in analysis of gene expression
|
Almudevar, Anthony
|
|
2006
|
3 |
3 |
p. 384-395
|
artikel
|
| 48 |
www.PDtrials.org: Increasing Parkinson’s Clinical Trial Awareness through the Internet
|
|
|
2006
|
3 |
3 |
p. 415-
1 p.
|
artikel
|
Tijdschrift beschrijving